Weekly Spotlight - 21.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Interactive Atlas Reveals Immune System Changes in Myeloma Patients

Researchers have created an interactive atlas to map immune system changes in patients with multiple myeloma. This tool helps understand how the immune system is affected by the disease, potentially leading to better treatment strategies and improved patient outcomes for those suffering from multiple myeloma.

Optimizing Sequencing of Bispecifics and CAR-T Cell Therapy in Relapsed/Refractory Myeloma Patients

The article discusses treatment options for relapsed or refractory multiple myeloma, comparing bispecific antibodies and CAR-T cell therapy. It explains how these therapies work and their potential benefits and challenges, helping patients with multiple myeloma understand their treatment choices.

MRD Testing Accelerates Drug Approvals in Myeloma Patients

The article discusses how Minimal Residual Disease (MRD) testing is becoming crucial in accelerating drug approvals for multiple myeloma. MRD tests help identify tiny amounts of cancer cells remaining after treatment, allowing for more precise patient monitoring and potentially faster approval of new therapies for multiple myeloma.

GSK's BCMA-Targeting Therapy Shows Promise in Myeloma Trial Results

GlaxoSmithKline (GSK) is conducting a clinical trial for a new treatment for multiple myeloma, a type of blood cancer. The trial aims to evaluate the safety and effectiveness of a combination therapy involving GSK's drug belantamab mafodotin and other treatments. This could potentially offer new hope for patients with multiple myeloma.